Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Omar Prado-Carrillo"'
Autor:
Omar Prado-Carrillo, Abner Arenas-Ramírez, Monserrat Llaguno-Munive, Rafael Jurado, Jazmin Pérez-Rojas, Eduardo Cervera-Ceballos, Patricia Garcia-Lopez
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 14; Pages: 7715
Chronic myeloid leukemia (CML) is a hematologic disorder characterized by the oncogene BCR-ABL1, which encodes an oncoprotein with tyrosine kinase activity. Imatinib, a BCR-ABL1 tyrosine kinase inhibitor, performs exceptionally well with minimal toxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae7ab9d6185fbf23e085555ab18a706e
https://doi.org/10.3390/ijms23147715
https://doi.org/10.3390/ijms23147715
Autor:
Prado-Carrillo, Omar1,2 (AUTHOR) oprado@live.com.mx, Arenas-Ramírez, Abner1 (AUTHOR) alex_abner.ar@ciencias.unam.mx, Llaguno-Munive, Monserrat1 (AUTHOR) muniv1250@hotmail.com, Jurado, Rafael1 (AUTHOR) fcojl@yahoo.com, Pérez-Rojas, Jazmin1 (AUTHOR) jazminmarlen@gmail.com, Cervera-Ceballos, Eduardo3 (AUTHOR) eduardocer@yahoo.com, Garcia-Lopez, Patricia1 (AUTHOR) pgarcia_lopez@yahoo.com.mx
Publikováno v:
International Journal of Molecular Sciences. Jul2022, Vol. 23 Issue 14, p7715-7715. 16p.